Nursing Activities for High Complexity Oncologic Care Patients
Quantifying and Measuring the Economic Impact of Nursing Activities During the Hospital Stay of High Complexity Oncologic Care Patients
Aperçu de l'étude
Statut
Statut
Les conditions
Les conditions
Description détaillée
Study design
The methodological approach used to achieve the objective of this research is quantitative. A mixed study design is being adopted:
- Retrospective study to determine the nature and volume of activity provided at nursing classes of patients whose admission is attributed to a specific DRG
- Longitudinal prospective study to determine the variability of costs of nurses with regard to DRG refund, comparatively to distribution of patients for every single section (high, medium, low complexity).
Study population The sample has been chosen considering the prevalence of hospitalizations per year in medical oncology U.O.C. related to certain DRG and characterized by greater complexity of care, so as to provide a useful information base for study. For the retrospective study the survey will be conducted on a sample of 150 patients. Patients will be enrolled at high, medium and low complexity of care, hospitalized for chemotherapy and for biliary obstructive urinary tract and in the first half of 2016. It is estimated that the sample represents 30% of the total number of admissions made in 2016. A prospective longitudinal study will take into consideration a sample of 150 patients with the same characteristics considered for enrollment in the retrospective study.
The study will include patients who under go: CHT with a duration of hospital stay of 2-3 days (microcitomi and NHL), CHT with a length of hospital stay of 4-5 days (sarcomas), CHT with a length of hospital stay > 5 days or at high doses (testicle cancer, Ewing's sarcoma and bone sarcoma) and patients with higher complexity care.
Patients of 18 years of age or less will be excluded, as well as patients that were transferred to other units while inpatient, patients transferred in U.O.C. of Oncology after major surgery procedures in other departments, and admissions that are outliers.
The duration for the monitoring phase on the allocation and the distribution of patients among the different sections of hospital care intensity (Intensità di cure, IC) and care complexity (Complessità Assistenziale, CA), based on the results obtained by the Triage of corridor (TriCO), is estimated for 3 months up to a maximum of six months starting from March 2016. For the collection of data relating to the amount and types of activities provided in the first half of 2016 is estimated to have a maximum of 30 days and others 30 days for the detection the relative DRG reimbursed for hospitalizations considered.
Survey instruments
- Professional Assessment Instrument (PAI). It is a tool that documents nursing processes implemented in a computerized way using nursing language according to the North American Nursing Diagnosis Association International (NANDA-I).
- Hospital discharge card (Scheda di dimissione ospedaliera, SDO). It is a tool that contains information about each patient discharged, that are necessary for the attribution to DRG and for finding the rate payable for each episode of hospitalization
- Scheda di mobilità interna dei pazienti. It is a card that contains data of Tri-CO at the entrance of the patient and any variations of that index during hospitalization.
Interventions The study will be presented to the manager and coordinator of the U.O.C. Medical Oncology through a moment of training/information.
In order to collect data on the variation of Tri-CO during hospitalization, and consequently the different allocation to U.O.C. of Oncology of patients in sections of low, medium and high complexity of care, a point of contact (nurse) will be identified who will deal with the collection and retention of such information in the manner set out in the research protocol.
Outcome measures
The primary outcome expected by the survey is the quantification of the volume of nursing activities provided to patients and its cost. In addition, we expect to realize economic indicators which make it possible to ascertain:
- Cost weight of the nursing staff on the DRG rate reimbursed in relation to the complexity care of the patient;
- Cost weight of the nursing staff on the reimbursement for hospitalization in connection with the DRG of patient discharge.
- Gap between theoretical and actual cost of nurses in relation to the care delivered for a specific patient; Knowledge of actual costs for each distinct and specific episode of hospitalization would enhance its "uniqueness". An economic analysis of labor nursing costs for individual patient could provide input for the determination of the costs of all the professionals of the Foundation, contributing to the improvement of corporate strategic management for resource allocation.
Statistical analysis Statistical analyses will be performed using methods of descriptive statistics and inferential statistics appropriate to the sample size and study variables. Prospective longitudinal study will be used to determine the frequency distribution and the variance on the stay of the patients in each individual section of hospital in-patient treatment which is attributed to a specific DRG. Then a factorial analysis and regression techniques will be used to measure the type of bond that exists between the dependent variable Y (nursing) and independent variables X1, X2, X3 ... (DRG, age, days of hospitalization, complications, etc). Then the analysis will continue by studying which variables will affect the distribution of patients for IC and CA level and how it can change this assignment during a single in-patient episode, creating a variability in costs of services paid.
Type d'étude
Type d'étude
Inscription (Anticipé)
Inscription
Contacts et emplacements
Coordonnées de l'étude
Coordonnées de l'étude
- Nom: Amelia Palinuro, PhD Student
- Numéro de téléphone: +393468599660
- E-mail: amelia.stop@hotmail.it
Sauvegarde des contacts de l'étude
- Nom: Maurizio Zega, PhD
- Numéro de téléphone: +390630154796
- E-mail: maurizio.zega@policlinicogemelli.it
Lieux d'étude
-
-
-
Roma, Italie, 00168
- Recrutement
- Universita Cattolica del Sacro Cuore
-
Contact:
- Amelia Palinuro, PhD Student
- Numéro de téléphone: +393468599660
- E-mail: amelia.stop@hotmail.it
-
Contact:
- Maurizio Zega, PhD
- Numéro de téléphone: +390630154796
- E-mail: maurizio.zega@policlinicogemelli.it
-
-
Critères de participation
Critère d'éligibilité
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
Méthode d'échantillonnage
Population étudiée
La description
Inclusion Criteria:
- CHT with a duration of hospital stay of 2-3 days (microcitomi and NHL),
- CHT with a length of hospital stay of 4-5 days (sarcomas),
- CHT with a length of hospital stay > 5 days (in case of high doses: testicle cancer, Ewing's sarcoma and bone sarcoma)
- Oncologic patients with higher complexity care.
Exclusion Criteria:
- Patients of 18 years of age or less
- Patients transferred to other units while inpatient
- Patients transferred in U.O.C. of Oncology after major surgery procedures in other departments
- Outlier admissions
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
Nombre de groupes / cohortes
Cohortes et interventions
Groupe / CohorteGroupe / Cohorte |
|---|
|
Retrospective cohort
150 oncologic patients belonging to major complexity DRGs
|
|
Perspective cohort
150 oncologic patients belonging to major complexity DRGs
|
Que mesure l'étude ?
Principaux critères de jugement
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Volume of Nursing Activity
Délai: Through study completion, based on the patients' discharge date. The first outcome assessments are expected in December 2016.
|
Count of nusing activities performed to patients in different complexity groups
|
Through study completion, based on the patients' discharge date. The first outcome assessments are expected in December 2016.
|
Mesures de résultats secondaires
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Cost weight of the nursing staff on the DRG rate reimbursed in relation to the complexity care (Complessità Assistenziale, CA) of the patient.
Délai: Through study completion, based on the patients' discharge date. The first outcome assessments are expected in December 2016.
|
Cost weight of the nursing staff on the DRG rate reimbursed in relation to the complexity care of the patient
|
Through study completion, based on the patients' discharge date. The first outcome assessments are expected in December 2016.
|
|
Cost weight of the nursing staff on the reimbursement for hospitalization in connection with the DRG of patient discharge
Délai: Through study completion, based on the patients' discharge date. The first outcome assessments are expected in December 2016.
|
Cost weight of the nursing staff on the reimbursement for hospitalization in connection with the DRG of patient discharge.
|
Through study completion, based on the patients' discharge date. The first outcome assessments are expected in December 2016.
|
|
Mean difference between theoretical and actual cost of nurses in relation to the care delivered for a specific patient.
Délai: Through study completion, based on the patients' discharge date. The first outcome assessments are expected in December 2016.
|
Difference between theoretical and actual cost of nurses in relation to the care delivered for a specific patient.
The nursing time cost expressed in minutes results from the standard cost for each nursing hour worked by a nurse.
The time in minutes of the performance is detected by the time indicated on standard nursing protocols considered for the study.
The time in minutes of a benefit provided to specific types of patients considered comes from the average execution time of nursing care.
|
Through study completion, based on the patients' discharge date. The first outcome assessments are expected in December 2016.
|
Collaborateurs et enquêteurs
Parrainer
Parrainer
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude
Début de l'étude
Achèvement primaire (Anticipé)
Achèvement primaire
Achèvement de l'étude (Anticipé)
Achèvement de l'étude
Dates d'inscription aux études
Première soumission
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Première publication
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Estimation)
Dernière mise à jour publiée
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Dernière vérification
Plus d'information
Termes liés à cette étude
Autres numéros d'identification d'étude
Autres numéros d'identification d'étude
- FAG14
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .